MarketPulse
L

$LFWD

3 articles found
3 positive
0 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Lifeward Shareholders Back Oramed Partnership to Diversify Into Biotech

Lifeward gains shareholder approval for strategic Oramed deal, securing up to $47M capital while expanding into oral delivery technology.
LFWDORMPstrategic partnershipclinical development
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Lifeward Regains Nasdaq Compliance After Stock Price Recovery

Lifeward Ltd. ($LFWD) has regained compliance with Nasdaq's $1.00 minimum bid price requirement, ending delisting risk for the medical technology company.
LFWDmedical technologyminimum bid price
GlobeNewswire Inc.GlobeNewswire Inc.··Na

ReWalk Exoskeleton Gains Aetna Coverage, Now Accessible Through Three Major Medicare Advantage Plans

Aetna approves Medicare Advantage coverage for ReWalk exoskeleton, expanding access to three major insurers serving 16 million beneficiaries and marking progress for wearable robotic technology reimbursement.
UNHLFWDHUMmedical deviceReWalk Personal Exoskeleton